Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4760428
Max Phase: Preclinical
Molecular Formula: C48H72O13
Molecular Weight: 857.09
Molecule Type: Unknown
Associated Items:
ID: ALA4760428
Max Phase: Preclinical
Molecular Formula: C48H72O13
Molecular Weight: 857.09
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(COCCCCCCCCCCCCCCCCC1=C2C=CC3=CC=CC4=CC=C(C=C1)C2C34)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C48H72O13/c1-56-35(30-58-47-45(55)43(53)46(38(28-50)60-47)61-48-44(54)42(52)41(51)37(27-49)59-48)29-57-26-15-13-11-9-7-5-3-2-4-6-8-10-12-14-17-31-20-21-34-23-22-32-18-16-19-33-24-25-36(31)40(34)39(32)33/h16,18-25,35,37-55H,2-15,17,26-30H2,1H3/t35?,37-,38-,39?,40?,41+,42+,43-,44-,45-,46-,47-,48+/m1/s1
Standard InChI Key: BYYPDZHGIKFEFU-MOKXEUNESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 857.09 | Molecular Weight (Monoisotopic): 856.4973 | AlogP: 4.54 | #Rotatable Bonds: 27 |
Polar Surface Area: 196.99 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.94 | CX Basic pKa: | CX LogP: 6.23 | CX LogD: 6.23 |
Aromatic Rings: 0 | Heavy Atoms: 61 | QED Weighted: 0.06 | Np Likeness Score: 1.28 |
1. Bauduin A,Papin M,Chantôme A,Couthon H,Deschamps L,Requejo-Isidro J,Vandier C,Jaffrès PA. (2021) Development of pyrene-based fluorescent ether lipid as inhibitor of SK3 ion channels., 209 [PMID:33049604] [10.1016/j.ejmech.2020.112894] |
Source(1):